Neogen (NEOG) Current Deferred Revenue (2021 - 2026)
Neogen's (NEOG) quarterly Current Deferred Revenue came in at $3.9 million in Q1 2026, down 32.4% year-on-year from $5.8 million in Q1 2025, and up 0.67% quarter-over-quarter from $3.9 million in Q4 2025.
Neogen (NEOG) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Neogen's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 32.4% year-over-year to $3.9 million in Q1 2026; TTM through Feb 2026 was $3.9 million, a 32.4% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, up 20.9% from the prior year.
- Current Deferred Revenue advanced to $3.9 million in Q1 2026 per NEOG's latest filing, from $3.9 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $6.8 million in Q1 2023 and bottomed at $3.8 million in Q3 2023.
- The 5-year median for Current Deferred Revenue is $5.5 million (2022), against an average of $5.1 million.
- Across the five-year window, Current Deferred Revenue jumped 60.4% in 2022 and sank 32.4% in 2026, its largest moves.
- Year by year, Current Deferred Revenue stood at $5.1 million in 2022, then fell by 7.95% to $4.7 million in 2023, then advanced by 20.77% to $5.7 million in 2024, then tumbled by 31.45% to $3.9 million in 2025, then increased by 0.67% to $3.9 million in 2026.
- Per Business Quant, the three latest NEOG Current Deferred Revenue figures stand at $3.9 million (Q1 2026), $3.9 million (Q4 2025), and $5.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 3.90 Mn |
| Nov 30, 2025 | 3.87 Mn |
| Aug 31, 2025 | 5.82 Mn |
| May 31, 2025 | 5.60 Mn |
| Feb 28, 2025 | 5.77 Mn |
| Nov 30, 2024 | 5.65 Mn |
| Aug 31, 2024 | 5.64 Mn |
| May 31, 2024 | 4.63 Mn |
| Feb 29, 2024 | 5.49 Mn |
| Nov 30, 2023 | 4.68 Mn |
| Aug 31, 2023 | 3.79 Mn |
| May 31, 2023 | 4.62 Mn |
| Feb 28, 2023 | 6.77 Mn |
| Nov 30, 2022 | 5.08 Mn |
| Aug 31, 2022 | 5.46 Mn |
| May 31, 2022 | 5.46 Mn |
| May 31, 2021 | 3.40 Mn |